HCAT
HCAT
NASDAQ · Health Care

Health Catalyst Inc

$1.19
+0.02 (+1.71%)
As of May 16, 2:08 AM ET ·
Financial Highlights (FY 2026)
Revenue
328.93M
Net Income
-188,156,334
Gross Margin
49.7%
Profit Margin
-57.2%
Rev Growth
+4.1%
D/E Ratio
0.62
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 49.7% 49.7% 29.0% 29.0%
Operating Margin -51.7% -46.5% 12.9% 14.1%
Profit Margin -57.2% -54.3% 10.8% 12.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 328.93M 316.13M 32.58M 30.28M
Gross Profit 163.48M 157.12M 9.46M 8.79M
Operating Income -170,057,754 -147,094,645 4.21M 4.28M
Net Income -188,156,334 -162,749,351 3.53M 3.69M
Gross Margin 49.7% 49.7% 29.0% 29.0%
Operating Margin -51.7% -46.5% 12.9% 14.1%
Profit Margin -57.2% -54.3% 10.8% 12.2%
Rev Growth +4.1% +4.1% +12.6% +17.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 16.89M 16.89M 50.32M 42.45M
Total Equity 27.08M 27.08M 108.46M 121.60M
D/E Ratio 0.62 0.62 0.46 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -116,331,350 -106,213,149 6.92M 5.56M
Free Cash Flow 3.08M 3.74M